Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nobuyuki Kiyosawa is active.

Publication


Featured researches published by Nobuyuki Kiyosawa.


Pediatrics International | 2005

Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)

Mamoru Ayusawa; Tomoyoshi Sonobe; Shigeru Uemura; Shunnichi Ogawa; Yoshikazu Nakamura; Nobuyuki Kiyosawa; Masahiro Ishii; Kensuke Harada

Abstract  Diagnostic guidelines for Kawasaki Disease was revised to meet the present situation in 2002. This issue intends to explain new guidelines and their backgrounds. Major alterations are interpretation of cases with 4 or fewer febrile days shortened by early intravenous immunoglobulin treatment, and the clinical importance of atypical (incomplete, or suspected) cases.


Circulation | 1982

Aneurysms of the coronary arteries in Kawasaki disease. An angiographic study of 30 cases.

Zenshiro Onouchi; S Shimazu; Nobuyuki Kiyosawa; Tetsuro Takamatsu; Kenji Hamaoka

Thirty patients with coronary aneurysms associated with Kawasaki disease underwent coronary arteriography. Of 53 aneurysms, five were saccular, 24 sacculofusiform, 19 fusiform and five tubular. When tubular aneurysms were included in the fusiform type, the incidence of each configuration in the right coronary artery was almost the same as that in the left coronary artery. The left anterior descending coronary artery had the most aneurysms, followed by the right coronary, left main and circumflex arteries. Right coronary aneurysms always involved the bifurcation or the region from which a branch vessel arose; 13 of 31 left coronary aneurysms did not involve the bifurcation.


Leukemia & Lymphoma | 2005

Cerebral thrombotic complications in adolescent leukemia/lymphoma patients treated with L-asparaginase-containing chemotherapy

Toshihiko Imamura; Akira Morimoto; Ryuichi Kato; Moriatu Izumi; Aki Murakami; Satoshi Matuo; Nobuyuki Kiyosawa; Gen Kano; Hiroshi Yoshioka; Tohru Sugimoto; Shinsaku Imashuku

We described the cerebral thrombotic complications developed in 2 adolescent patients treated with L-asparaginase-containing regimens. For determining risk factors, we retrospectively analysed hemostatic markers in 19 pediatric patients with leukemia or lymphoma who were treated with either 1 of the 2 L-asparaginase-containing regimens; 11 were treated with VLP1 and the remaining 8 were treated with the VLAD protocol. The data indicated that low coagulation factors in association with increased plasma D-dimer levels during or post-L-asparaginase administration combined with fresh frozen plasma infusion might have activated coagulation processes in these patients. Careful management is required to prevent such episodes in patients with markedly decreased coagulation factors and increased D-dimer levels following L-asparaginase administration.


Pediatric Cardiology | 1991

Asymptomatic myocardial infarction in Kawasaki disease: Long-term prognosis

Isao Shiraishi; Zenshiro Onouchi; Takashi Hayano; Kenji Hamaoka; Nobuyuki Kiyosawa

SummaryEight patients with Kawasaki disease who had sustained asymptomatic myocardial infarction 8–15 years ago (mean, 13.1 years) were reexamined by various noninvasive cardiac function tests to assess long-term prognosis.At present, electrocardiograms (ECGs) are normal in six patients. However, all eight patients had a prolonged preejection period (PEP) to left ventricular ejection time (LVET) ratio 30 s after amylnitrate (AN) inhalation. Six patients had perfusion defects by exercise thallium-201 myocardial scintigraphy, and two patients developed ST segment depression in treadmill exercise testing.These patients are symptom-free even though their physical activity has not been restricted. Yet they proved to have serious abnormalities suggesting sequelae of myocardial infarction or existing myocardial ischemia. Judging from the results of noninvasive cardiac function tests and recently performed coronary angiography, five of the eight patients require coronary bypass surgery.


Pediatrics International | 1995

Optimal dosage and differences in therapeutic efficacy of IGIV in Kawasaki disease

Zenshiro Onouchi; Masayoshi Yanagisawa; Tsuneo Hirayama; Nobuyuki Kiyosawa; Hiroshi Matsuda; Mitsuyoshi Nakashima

In an initial study, three groups of patients with Kawasaki disease received either aspirin alone or alkylated immunoglobulin G intravenous preparation (IGIV) 200 mg/kg daily x3 days + aspirin, or 400 mg/kg alkylated IGIV daily x3 days + aspirin. In a second study, three groups of patients were treated with either 100, 200 or 400 mg/kg of native IGIV in combination with aspirin daily for 5 days.


Pediatrics International | 2009

Neutropenia in the acute phase of Kawasaki disease and prevention of coronary artery aneurysm

Zenshiro Onouchi; Kenji Hamaoka; Seiichiro Ozawa; Koichi Sakata; Nobuyuki Kiyosawa; Hisato Ito

Background:  The significance of neutropenia in Kawasaki disease (KD) has not been fully elucidated as yet.


Pediatric Hematology and Oncology | 1988

Anthracycline—Induced Congestive Heart Failure in two Pediatric Leukemia Cases and Long Term Follow—Up

Eikan Koh; Shinsaku Imashuku; Nobuyuki Kiyosawa; Tadashi Sawada

Endomyocardial biopsy was performed on two leukemia patients who had recovered from severe congestive heart failure (CHF) due to anthracycline cardiomyopathy at 41 months and 47 months after CHF. Microscopic myocardial findings in both patients revealed that myocytes were hypertrophic, but interstitial fibrosis was not observed, suggesting a compensatory mechanism for the damaged heart muscle during the acute episode of CHF. The improvement of clinical symptoms and the normalization of cardiac function, including fractional shortening and ECG changes, is thought to have been associated with this myocardial repairing process.


Pediatrics International | 2010

Survey of severe respiratory syncytial virus infection in Kyoto Prefecture from 2003 to 2007

Hisato Ito; Toshio Osamura; Fumiaki Nakajima; Daisuke Fujiwara; Yasumichi Kuwabara; Toru Yamamoto; Tetsuya Yasuno; Hiroshi Komatsu; Zenrou Kizaki; Kenji Kishida; Yuichi Akiyama; Tadaki Oomae; Kouji Nakajima; Akitoshi Nakamura; Nobuyuki Kiyosawa; Ryuta Nisikomori

Background:  Respiratory syncytial virus (RSV) infection in infants can develop into a severe condition.


Blood Coagulation & Fibrinolysis | 2015

Exsanguinating bleeding following tooth extraction in a 12-year-old girl: a rare case of acquired haemophilia A.

Kimito Todo; Tadaki Ohmae; Toshio Osamura; Nobuyuki Kiyosawa; Mitsuhiko Sugimoto; Midori Shima; Toshihiko Imamura; Shinsaku Imashuku

Acquired haemophilia A (AHA) is a life-threatening haemorrhagic disorder that occurs with various underlying conditions such as autoimmune disease, drug reactions, lymphoproliferative diseases, solid tumours and pregnancy/postpartum status. However, in half of all reported cases, the underlying disease is unknown. Most AHA cases develop in adults; paediatric/adolescent cases are extremely rare. The main clinical symptom is bleeding into the skin, muscles, soft tissues and/or mucous membranes. Here, we report the case of an otherwise healthy 12-year-old girl who presented with prolonged bleeding postexodontia. After being diagnosed with AHA, she was successfully treated with recombinant activated factor VII infusion and oral prednisolone. To avoid such unanticipated bleeding when performing dental extraction, preoperative haemostatic screening tests are recommended.


Japanese Circulation Journal-english Edition | 2005

Long-Term Changes in Coronary Artery Aneurysms in Patients With Kawasaki Disease : Comparison of Therapeutic Regimens

Zenshiro Onouchi; Kenji Hamaoka; Koichi Sakata; Seiichiro Ozawa; Isao Shiraishi; Toshiki Itoi; Nobuyuki Kiyosawa

Collaboration


Dive into the Nobuyuki Kiyosawa's collaboration.

Top Co-Authors

Avatar

Zenshiro Onouchi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Kenji Hamaoka

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Isao Shiraishi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Koichi Sakata

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Seiichiro Ozawa

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Shinsaku Imashuku

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Toshihiko Imamura

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Toshiki Itoi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Aki Murakami

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Akira Morimoto

Kyoto Prefectural University of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge